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Abstract: Caenorhabditis elegans, a 1 mm long free-living nematode, is a popular model animal that
has been widely utilized for genetic investigations of various biological processes. Characteristic
features that make C. elegans a powerful model of choice for eukaryotic genetic studies include
its rapid life cycle (development from egg to adult in 3.5 days at 20 ˝C), well-annotated genome,
simple morphology (comprising only 959 somatic cells in the hermaphrodite), and transparency
(which facilitates non-invasive fluorescence observations). However, early approaches to introducing
mutations in the C. elegans genome, such as chemical mutagenesis and imprecise excision of transposons,
have required large-scale mutagenesis screens. To avoid this laborious and time-consuming procedure,
genome editing technologies have been increasingly used in nematodes including C. briggsae and
Pristionchus pacificus, thereby facilitating their genetic analyses. Here, I review the recent progress
in genome editing technologies using zinc-finger nucleases (ZFNs), transcriptional activator-like
nucleases (TALENs), and clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9
in nematodes and offer perspectives on their use in the future.
Keywords: nematode; C. elegans; transposon; TALEN; CRISPR/Cas9; cell-specific analysis
1. Introduction
The nematode C. elegans became a powerful model organism just over 50 years ago [1]. This
tiny animal has greatly contributed to investigations of the functions of genes in development and
cellular biology. One advantage of using C. elegans as a model animal is its simple morphology;
the adult hermaphrodite is composed of only 959 somatic cells, including 302 neurons, and cell number
does not vary among individuals. Researchers have tracked the fate of every cell, from fertilization
to adulthood, in live animals and have generated a complete cell lineage [2]. This insight into cell
lineage has contributed enormously to research in the field of developmental biology. The wiring and
connectivity of neurons in C. elegans have been completely reconstructed from electron micrographs [3].
Therefore, this well-defined nervous system simplifies investigations of the neural circuitry underlying
behavioral plasticity. Features that make the nematode highly amenable to laboratory research also
include its small size, short life cycle and ability to survive long-term freezing for storage. These
advantageous features have allowed C. elegans researchers to uncover novel biological mechanisms,
such as apoptosis, and develop novel techniques, such as green fluorescent protein (GFP) tagging, in
the life sciences research field.
C. elegans is a genetically tractable model system, for which many genetic resources and tools
have been developed. There are approximately 20,359 protein-coding genes in C. elegans (WormBase
referential freeze WS250, November 2015). In OrthoList, a compendium of C. elegans genes with
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human orthologs, 7663 protein-coding genes are predicted to have human orthologs, corresponding
to approximately 38% of the C. elegans genome [4]. Furthermore, 60%–80% of human genes are
represented by an ortholog in the C. elegans genome [5]. More importantly, 40% of genes known to be
associated with human diseases are represented by orthologs in the C. elegans genome [6].
To clarify functional roles of C. elegans genes, various genetic methods have been developed and
adapted before emergence of recent genome engineering techniques. In forward genetic screening,
worms are treated with mutagens such as ethyl methane sulfonate (EMS) to induce DNA lesions and
mutants with a target phenotype. Subsequent gene mapping and detailed analyses of the mutant
phenotype allow elucidation of the gene’s function. As a complement to forward genetics, reverse
genetics offers opportunities to examine the function of a gene by analyzing the phenotypic effects of
targeted gene sequence alteration. RNA interference (RNAi) has served as a powerful reverse genetic
tool for large-scale genetic screening and to study gene function by examining the consequences of
targeted gene knock-down. However, RNAi fails to completely suppress gene expression and provides
only temporally inhibition of gene function only temporally. Screening of worms with deletions of
specific target DNA by the C. elegans Gene Knockout Consortium and the Japan National Bioresource
Project has offered opportunities to examine the phenotypic effects of a targeted gene knock-out.
However, these resources do not completely include mutants with deletions in a desired genomic
region. Therefore, it has been needed to establish a strategy for inducing targeted gene knock-out
at will.
In compatible with forward and reverse genetic screening, microinjection of a gene of interest has
been an indispensable genetic technique to study gene functions in C. elegans. The microinjection of
genes including fluorescent protein-coding genes into the gonad of the adult hermaphrodite results
in the formation of semi-stable extrachromosomal arrays that are comprised of many copies of the
injected DNA [7]. The microinjection under the control of a cell-specific promoter has been used for an
extrachromosomal rescue experiment that enables identification of a cell-specific role of the transgene.
The transgenes, which are typically overexpressed in somatic tissues and silenced in the germline
and early embryo, can be integrated into the genome by UV (ultraviolet) irradiation or microparticle
bombardment [8,9]. These integration methods have allowed the generation of low-copy transgenes,
which are expressed at closer to endogenous levels [10]. However, this experiment is less efficient,
time-consuming, and not easily able to control genomic location for gene insertion. Thus, a strategy
for inducing a stable gene knock-in at a desired genomic location has been required in the nematode
research field.
Due to these requirements for targeted genome editing, C. elegans geneticists have developed
methods based on the Mos1 transposon system [11,12]. Then, zinc-finger nucleases (ZFNs) [13],
transcription activator-like effector (TALE) nucleases (TALENs) [14,15], and RNA-guided clustered
regulatory interspaced short palindromic repeats (CRISPR)/Cas9 endonuclease systems have emerged
as the revolutionized techniques adapted for creating locus-specific mutations in nematodes [15–22].
In this review, I provide a historical overview of this research field and discuss recent implementations
of genome editing techniques in nematodes.
2. Development of Gene Editing Protocols for Nematodes
2.1. Site-Restricted Editing by Mos1
Before the revolution of the current genome editing technologies, methods based on the Mos1
transposon system allowed for targeted genome editing in C. elegans [11,12]. Robert and Bessereau
reported that the Drosophila element Mos1 can also be used to produce double strand breaks (DSBs) and
initiate gene editing [11]. In the experiments described in that paper, a repair template was constructed
by preparing a transgene containing sequences homologous to the target genome region. The repair
template was co-injected into the germline of a Mos1-insertion mutant with a vector enabling the
expression of the Mos transposase using the heat-shock promoter hsp-16.48. Heat-shock treatment
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triggered DSBs at the target site, which were repaired by transgene-mediated gene conversion. This
process allowed for mutations in the transgene to be copied at a specific locus at frequencies ranging
from 10´5 to 10´4 events per F1 progeny. The mutations were successfully inherited by offspring.
Frøkjær-Jensen et al. developed methods for Mos1-mediated single-copy insertion (MosSCI) that
enables the insertion of single copies of transgenes into well-defined genomic loci [12] and optimized
the efficiency of insertion [23]. The prerequisite for these techniques was the insertion of the Mos1
element into the target genomic region. Although efforts to generate a comprehensive Mos1-inserted
mutant library are in progress, the ability to modify the genome with this technique is limited to
genetic loci near transposons.
2.2. Universal Editing with ZFNs, TALENs and CRISPRs
Early methods for artificially generating DSBs at targeted genomic regions were based on ZFNs.
ZFNs are chimeric proteins composed of DNA-binding Cys2His2 zinc finger motifs and a nonspecific
FokI nuclease domain. Each finger is about 30 amino acids and interacts with a separate DNA triplet.
Both natural and artificial zinc fingers have been characterized and known to bind to all 5’-GNN-3’,
many ANN and CNN, and some TNN triplets. In addition, the modular nature of the zinc fingers
enables them to be assembled in arbitrary combinations. In general, three zinc fingers are combined to
recognize a specific 9 bp DNA sequence with nanomolar affinity, and additional fingers can be used
to increase specificity. DSBs require the dimerization of two FokI nuclease domains, and ZFNs are
used in pairs with specificity to opposing DNA strands, which enables assembly on both sides of the
targeted site. This property enhances the specificity of ZFN targeting. Because zinc fingers exist for
many of the DNA triplets, varying the number and types of fingers in each chimera would theoretically
allow for targeting nucleases to the desired genomic loci. Carroll and colleagues initially designed a
synthetic target DNA sequence for a previously characterized ZFN [13]. The synthetic target DNA
along with the plasmid expressing the nuclease with a heat-shock promoter were co-injected into
germline cells to generate an extrachromosomal array. Expression of the nuclease by heat-shock
treatment induced mutations in more than 20% of the target sites. In subsequent experiments, an
endogenous genomic sequence was targeted using a pair of designed ZFNs. This experiment achieved
mutations in approximately 20% of the target sites by heat-shock induction. This study was the first
to demonstrate that custom-engineered ZFNs could effectively generate targeted DSBs in nematode
DNA. Although the repair of these breaks by the end-joining mechanism often generated mutations
at the targeted locus, the procedure had little practical value as a genetic tool because the mutations
were generated in somatic cells and hence were not inherited by offspring. Thus, these studies did not
achieve the goal of heritable genome editing using ZFNs. The authors proposed that direct injection of
mRNA into the germline might be effective for producing inherited mutations.
In a landmark paper on genome editing released in 2011, Wood et al. demonstrated heritable
genome editing using ZFNs in both C. elegans and C. briggsae [14]. In the experiments described in this
paper, the endogenous gene ben-1 was initially targeted because the phenotype of ben-1 heterozygous
mutants can be scored easily by analyzing mobility on the paralysis-inducing drug benomyl. To attain
heritable mutations in C. elegans, the investigators set the precedent of using mRNA, rather than DNA,
delivery for getting germline production. As a proof of principle, the authors injected gonads with
ZFN-encoding mRNAs carrying 5’ and 3’ untranslated regions amenable to germline translation and
obtained ben-1/+ mutants at a frequency of approximately 3% in F1 progeny. To establish a strategy for
identifying mutants by molecular genotyping rather than relying on a visible phenotype, they targeted
the REX-1 locus; REX-1 recruits the dosage compensation complex (DCC), thereby reducing gene
expression. Using the CEL-1 assay, the authors isolated 18 independent mutant lines from 338 CEL-1
reactions, indicating that molecular genotyping was an effective method for phenotypic selection.
In TALENs, a nonspecific FokI nuclease domain is fused to a customizable TALE domain
which contains tandem repeats of 33 or 34 amino acid segments and recognizes a predictable DNA
sequence [24]. Residues 12 and 13 of the segment, referred to as repeat variable diresidues (RVDs),
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determine the base-specific binding (HD to C, NI to A, NG to T, NN to G) [25,26]. Sequence-specific
DNA recognition by large TALE domains directs the nuclease, and the nuclease introduces DSBs at a
prospective target site. Erroneous repair by end-joining often yields a mutagenic deletion or insertion
at this breakpoint [27]. Compared with that of ZFNs, the recognition sequence of TALEs is relatively
simple, and TALEs can be designed to bind to almost any sequence. Moreover, TALENs also bind as
pairs, which also enhances specificity like ZFNs do. These features of TALEs are advantageous for
many researchers who use genome editing techniques.
Woods et al. first utilized TALENs in nematodes as reported in their paper describing ZFNs [14].
TALEN-encoding mRNAs carrying 5’ and 3’ untranslated regions designed to target the ben-1 gene
were injected into the C. elegans germline [14]. This method resulted in many TALEN-induced ben-1
mutations at a frequency of 1.1% in F1 progeny, and the same approach has been applied to C. species 9
(now called C. nigoni; 2.4% frequency) and P. pacificus (6.8% frequency) as described in a subsequent
paper [15]. Wei et al. have also used TALENs in C. briggsae and C. tropicalis [28,29]. The isolation of
targeted mutants in C. elegans has typically relied on visible phenotypes or fluorescent markers such as
GFP. In addition, molecular genotyping using CEL-1 assays [14], polyacrylamide electrophoresis [28],
and heteroduplex mobility assays [30] has also been used to identify mutations that are not associated
with a visible phenotype.
Although genome editing using TALENs has almost completely overcome the limitations
associated with some target sequences, the technique requires the laborious custom design of TALE
repeat segments. The CRISPR/Cas9 system emerged as a conceptually simple method that can be
used as an alternative to TALENs [31–33]. In bacteria and archaea, the CRISPR locus functions with
Cas proteins to facilitate an adaptive immune system response against invading foreign DNA, such as
viral DNA or plasmids. The foreign nucleotides are incorporated into the CRISPR locus in the host
genome, which results in short CRISPR RNAs (crRNAs) that direct the sequence-specific cleavage
of homologous target dsDNA by Cas endonucleases. Previous studies with the type II CRISPR/Cas
system, which requires the nuclease Cas9, a targeting crRNA and an additional trans-activating crRNA,
have revealed that fusing the targeting and trans-activating RNAs to form a single guide RNA (sgRNA)
is sufficient to direct Cas9-mediated target cleavage [31]. This system has been used for genome editing
in other model organisms because of the simplicity in designing a sgRNA.
Friedland et al. initially constructed a plasmid that drives the expression of the gene encoding
Cas9 using the germline-specific eft-3 promoter [16]. In that paper, klp-12 and Y61A9LA.1, genes
with an unknown loss-of-function phenotype, were targeted. The researchers isolated klp-12 and
Y61A9LA.1 mutations in 80.3% and 18.1% of the F1 worms screened, respectively. With respect to the
klp-12 locus, 27 of 80 F1 worms carried a homozygous mutation. This mutation frequency is high
enough to preclude the requirement of an obvious phenotype or visible selection marker. Like the
TALEN system, the CRISPR system has been also proven to be useful for researchers working with
non-Caenorhabditis nematodes. Witte et al. have successfully used CRISPR system-mediated gene
inactivation in P. pacificus [34]. Thus, the CRISPR system is undoubtedly a versatile method to facilitate
genome editing in the nematode.
Other research groups have also developed useful protocols and have demonstrated that heritable
changes in nematode genes can be induced using the CRISPR/Cas9 system [15,17–22,35]. The protocols
used in these experiments primarily differ with respect to delivery of the CRISPR/Cas9 effector
complex (DNA, RNA, or protein) and the methods used to identify mutations (PCR screen, visible
markers, or obvious phenotypes). For these experiments, most of the research groups expressed Cas9
under the control of the eft-3 promoter. On the other hand, Boxem’s group found the possibility that
expression of Cas9 from the eft-3 promoter causes embryonic lethality. The authors expressed Cas9
using a heat-shock promoter within a limited time frame to prevent the lethality effects observed with
the use of the eft-3 promoter and indicated that the use of the heat-shock promoter for Cas9 expression
might be better than that of the eft-3 promoter [21]. Other laboratories have used Cas9 and sgRNAs
transcribed in vitro [17,19] or crRNAs and tracrRNAs transcribed separately in vitro [15]. In one unique
Int. J. Mol. Sci. 2016, 17, 295 5 of 13
protocol, similarly to the RNAi feeding strategy, sgRNA was delivered to worms via bacterial feeding
to achieve gene disruptions in a time- and labor-saving manner [36]. In this protocol, worms carrying
pie-1p::Cas9 DNA were fed HT115 bacteria transformed with sgRNA. The mutation rates observed for
the bli and dpy loci in this feeding protocol were low compared with the injection method, at 1.40%
and 0.92%, respectively. However, the authors have proposed that the protocols could potentially be
redesigned to enable large-scale studies using a worm sgRNA library.
In brief, current ZFN, TALEN and CRIPSR systems have made possible important advances, but
each has advantages and disadvantages in genome editing. In Zinc fingers, the context-dependency
of the binding preference is that Zinc fingers exhibit context-dependent binding effects because
of interactions between adjacent modules assembled into a larger array. In addition, assembly of
functional ZFNs with the desired DNA-binding specificity remains a laborious process that requires
extensive cell-based screening. In contrast, because TALE repeat domains exhibits fewer context-
dependent preferences, researchers can simply assemble them in a modular fashion using a simple
one-to-one code between individual repeats and the four possible DNA nucleotides. Frequency of
off-target effects of TALENs is relatively low because of the length of the target sequence (15–19 bp), the
higher specificity of the TALE DNA-binding domain, and the need of FokI dimerization to reconstitute
endonuclease activity. On the other hand, despite these advantages over ZFNs, construction of novel
TALE arrays still remains labor-intensive partly due to their repetitive sequences. In terms of target
design simplicity, sgRNAs can be designed readily and cheaply to target nearly any genomic sequence
specifically. Furthermore, the efficiency of the CRISPR system is high compared with the TALEN
system. However, multiple mismatches between the guide RNA and its complementary target DNA
sequence can be tolerated, thereby causing undesired off-target mutagenesis. Recent studies have
demonstrated in other organisms that the use of dual nickases for Cas9 could reduce the potential
off-target mutagenesis. Therefore, application of this strategy further revolutionizes the genome
editing technology in the nematodes.
2.3. Imprecise and Precise Repair Using ssOligo and dsDNA
Genome editing techniques are a promising method for introducing DNA sequences encoding
GFP or other tags and large-scale deletions at DSB sites. The methods for knock-in largely rely on the
precise homology-dependent repair (HDR) of DSBs, in which a donor template that carries homology
arms can be integrated during the repair process. Single-stranded oligonucleotides (ssOligos) and
double-stranded DNA (dsDNA) including PCR fragments and plasmid DNAs, all of which contain
homology arms, have been used as HDR donor templates [37]. ssOligos and PCR fragments can be
easily designed and synthesized within a few days, and their use facilitated HDR-mediated knock-in.
On the other hand, plasmid DNAs require cloning but can accommodate gene-sized edits and longer
homology arms during repair processes. A previous evaluation of donor templates indicated that
ssOligos are the preferred template in C. elegans, owing to their efficiency as well as ease of use
(average frequencies for ssOligos and dsDNAs are 52% and 20%, respectively) [38]. In addition
to HDR, other repair mechanisms also serve as inducing knock-ins and deletions at the targeted
genomic loci. Van Schendel et al. have described an unexpected finding that while somatic cells
use non-homologous end-joining (NHEJ), germ cells use exclusively polymerase theta-mediated
end-joining (TMEJ), a simple repair mechanism requiring only one nucleotide as a repair template [39].
The researchers have demonstrated that polymerase theta is solely responsible for the vast majority of
insertions and deletions that occur during the natural evolution of C. elegans. In addition, the imprecise
end-joining repairs as well as template-mediated imprecise and precise HDRs have induced deletion
mutations of variable length at the site of the DSB.
Lo et al. have demonstrated for the first time that TALENs can be used to introduce precise changes
at endogenous sites using HDR templates [15]. This study was the first evidence that engineered
nucleases and exogenous ssOligos as repair templates could be used to achieve heritable changes
consisting of single nucleotide changes or insertions (e.g., HA tag) through precise HDR in nematodes
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at frequencies ranging from 0.2% to 4.0%. Additionally, FLP recombinase was introduced into the
strains possessing FRT sites flanking a cis-acting regulatory motif to knock out ~1 kb of DNA, resulting
in the removal of all the cis-regulatory information. By using an ssOligo, Lo et al. also demonstrated
precise insertion of the HA tag gene in P. pacificus (1.0% frequency). These results were the first to
demonstrate tagging of an endogenous gene in a manner leaving no detectable marks other than
the tag.
The CRISPR/Cas9 system has been also used with HDR templates. Dickinson et al. has generated
HDR-mediated in-frame gfp insertions and targeted mutations with an average frequency of 22% [40].
The authors constructed an HDR template comprising the C-terminal 1.5 kb sequence of the nmy-2 gene
(illustrated as Gene A in Figure 1) fused in-frame to gfp, the nmy-2 3’ UTR, and the unc-119(+) selection
marker along with 1.5 kb of downstream genomic sequence (Figure 1) [40]. The unc-119(+) gene was
flanked by loxP sites, which allowed for the excision of this gene by expression of Cre recombinase.
At nearly the same time, Katic et al. also demonstrated transgene-induced gene conversion of the
daf-2(m579) allele through Cas9-induced DSB repair by a wild-type sequence [19]. The investigators
constructed a sgRNA targeting a 20 bp sequence in daf-2 that overlapped with the m579 mutation. The
sgRNA was co-injected with a plasmid bearing the 715 bp wild-type daf-2 sequence, which causes a
missense change from m579 into the wild-type sequence [19]. Instead of the plasmid, ssOligos and PCR
fragments with short (~30–60 bases) homology arms was previously examined as a donor template [41].
This micro-homology arm also enabled gene conversion and generated precise nucleotide changes
via the CRISPR/Cas9 system. Furthermore, a variety of sequences encoding protein tags, such as
V5, 3xFlag, Myc, and OLLAS, with short homology arms can be inserted into the desired target site
through precise HDRs [42].
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Figure 1. Schematic of homologous recombination-mediated gfp insertion using TALENs or Cas9.
The unc-119(+) selection marker in the resulting gfp-inserted worms can be excised by injecting Cre
reco binase. The orange, blue, and cyan genomic regions are gene A, the 3’ UTR of gene A, and gene B,
respectively. The figure was adapted from Dickinson et al. [40].
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In terms of deletion experiments, Lo et al. showed that deletions can be induced either immediately
adjacent to the DSB by the end-joining mechanism (2.5% frequency) or distant from the DSB by HDR
(13.1% frequency) using TALEN [15]. In another report, co-injection of worms with dual sgRNAs
and Cas9 DNA has successfully induced the deletion of a chromosomal segment at least 24 kb in
length [43]. Paix et al. have also reported that large deletions can be created directly by end-joining
mechanism using Cas9 and sgRNA pairs targeting the 5’ and 3’ ends of mbk-2 and the swan-1/swan-2
operon at 2.8% and 1.6% efficiencies, respectively [42]. Authors then examined whether ssOligos could
be used to precisely create gene-length deletions by HDR and attempted to delete an entire ORF using
an ssOligo targeting the K08F4.2 gene containing 51–80 bp micro-homology arms that flanked the
sgRNA excision sites. Using this technique, they succeeded in generating large deletions with precise
breakpoints in the K08F4.2 gene at a frequency of 3.3%.
3. Optimization of the CRISPR System
Along with developments using the CRISPR system, several strategies for efficient identification
of genome-edited worms have also been established in C. elegans. One such strategy is antibiotic
resistance selection. Resistance to hygromycin B conferred by the HygR gene provides an efficient
selection method in C. elegans. Thus, Chen et al. have combined this selection method with the CRISPR
system and have created a HygR cassette flanked by ~2 kb of DNA sequence homologous to either
side of ben-1a sites [35]. CRISPR-based site-directed insertion of the HygR gene enabled hygromycin
B-resistant selection of the desired ben-1 mutants. A toolkit composed of template-mediated repair
cassettes that contain both an antibiotic resistance gene and a fluorescent visual maker, which facilitates
identification of worms carrying the repair template, has also been developed [44].
Although these methods have facilitated the identification of specific mutants, a strategy that
did not involve introducing an exogenous sequence at the targeted locus or marker mutations was
still desired. Therefore, Dickinson et al. have designed a plasmid that includes both a fluorescent
tag gene and the self-excising cassette (SEC) carrying a drug resistance gene, a visible phenotypic
marker, and a heat-shock-inducible Cre recombinase gene [45]. Incorporation of the SEC from the
plasmid into genomic loci permits easy excision of unwanted sequences upon heat-shock treatment
after identification of the desired mutant using drug selection and screening for a visible phenotype.
Mello and colleagues have reported a “co-CRISPR” strategy that facilitates the identification of
functional sgRNAs and increases the yield of transgenic worms carrying an end-joining or homologous
recombination event (illustrated in Figure 2) [46]. The authors have found that approximately half
of the sgRNAs tested are not effective in practice. This result is partly because conventional markers
such as rol-6 result in false-positive mutant identification, and many injections fail to produce mutant
progeny, even if high-quality reagents are used. Therefore, as an efficient marker, Mello et al. used an
sgRNA targeting the muscle structural gene unc-22, which has been previously proven to be active in
generating CRISPR/Cas9-induced end-joining mutations, leading to an easily observable paralyzed
twitching phenotype [47]. The selection based on the proven end-joining-induced phenotype would
facilitate efficient identification of animals in which the CRISPR system was active. To examine this
co-CRISPR strategy, the researchers co-injected the unc-22 sgRNA with targeted sgRNAs for avr-14 and
avr-15 or for pie-1b and pie-1c. Interestingly, selection based on the twitching phenotype dramatically
increased the yield of animals in which a targeted sgRNA was active.
Arribere et al. have established a dominant phenotypic oligonucleotide template conversion
strategy [48]. In this strategy (referred to as co-conversion strategy), instead of the sgRNA that
induces end-joining-mediated mutations, an sgRNA and donor oligonucleotide to create the dominant
phenotypic mutation such as rol-6(su1006) are co-injected with an sgRNA and donor oligonucleotide
to create a mutation in the desired gene. By identifying the desired mutation among F1 progeny
heterozygous for the dominant marker mutation, F2 worms that have lost the marker mutation can
be isolated with the desired mutation in an unmarked genetic background. Arribere et al. have also
identified one mutation in dpy-10(cn64) and one mutation in sqt-1(e1350) as effective dominant markers.
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Recently, the repair of a temperature-sensitive lethal point mutation has been used as an alternate
co-conversion marker [49]. This strategy promises robust selection, minimal screening, and has no
requirement for out-crossing marker mutations.
In addition to these streamlined screening methods, another group has described the optimization
of CRISPR target choices. A new sgRNA guide design strategy that vastly improved the efficiency of
editing with Cas9 has been established [50]. The strategy uses sgRNA with a 3’ GG addition to the
target-specific sequence, which is key for improving the frequency of mutagenesis. When paired with
the co-CRISPR approach, this technique offers the most reliable method of achieving precise genome
editing in nematodes.
The CRISPR-mediated HDR protocols have also been improved in another manner. As an
alternative to conventional protocols, the direct injection of recombinant Cas9 protein complexed
with guide RNA into C. elegans induces targeted gene disruption and yields HDR-mediated edits
with frequencies ranging from 3.3% to 9.4% [18,51]. This strategy obviates the need to optimize
DNA sequences for efficient expression of Cas9 and guide RNAs. Combined with the co-CRISPR
strategy, Cas9/sgRNA ribonucleoprotein complexes have been proven more efficient and robust for
use with low-efficiency guide RNAs and generating complex edits [51]. The author has established a
direct-delivery protocol that increases the number of injected animals that produce mutant progeny
(identified at frequencies ranging from 2% to 70% of F1 progeny), representing a 10-fold improvement
over conventional plasmid-based protocols.
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Figure 2. Overview of the co-CRISPR strategy for efficiently identifying functional sgRNAs targeting
avr genes. sgRNA targeting unc-22, a gene associated with the twitcher phenotype, was co-injected with
sgRNAs targeting avr-14 and avr-15, the Cas9 expression vector, and the rol-6 transformation marker.
The co-injection of a functional unc-22 sgRNA reduced the false-positive rate in the identification of
mutants. Figure 2 was adapted from Kim et al. [46].
4. Use of Genome Editing Tools to Create New Methods for C. elegans
In C. elegans, genetic studies can be conducted in a cell-specific manner. This advantage enables
the conditional editing of a targeted sequence in the C. elegans genome. Conditional editing allows for
the examination of genes associated with an embryonic lethal phenotype. Recently, Cheng et al. have
developed a novel method to generate conditional knock-outs by expressing TALENs in somatic cells
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(referred to as somatic TALENs) [52]. The authors targeted the cor-1 gene, a worm ortholog of mouse
actin-binding protein coronin. A cor-1 null mutation causes embryonic lethality, and its function was
not known. The authors revealed that expression of a somatic TALEN targeting the cor-1 under the
Q-cell-specific promoter causes the migration defects of the AQR and PQR neurons that descended
from the Q-cell in C. elegans larva, indicating the role of the cor-1 gene in Q-cell development. Thus,
conditional knock-out was established by germline transformation with plasmids encoding TALENs
using a cell-specific or inducible promoter. A similar strategy has also been established with the
CRISPR system under the control of other cell-specific promoters. This strategy has helped to gain a
further mechanistic insight into cor-1 [53] and to uncover roles of several other embryonic essential
genes, including the dynein intermediate chain and a cytokinetic scaffold protein Anillin [36,54,55].
In terms of conditional protein depletion, more recently, the auxin-inducible degradation (AID)
system discovered in plants was applied to C. elegans [56]. It has been known through other model
organisms that expression of an Arabidopsis TIR1 F-box protein mediates robust auxin-dependent
degradation of degron-tagged targets by proteasomes. As proof of principle, the expression of TIR
enabled rapid, reversible, auxin-dependent depletion of nuclear and cytoplasmic targets in diverse
somatic and germline tissues throughout development in C. elegans.
Recently, Yumerefendi et al. have used Cas9-mediated homologous recombination with an
interesting twist: a gene encoding light-activated protein was used as a repair template in place of
tagged proteins [57]. The authors inserted a gene for light-activated nuclear shuttle proteins (referred
to as LANS), which can change their nuclear localization upon light stimulation, into the C. elegans
lin-1 locus via Cas9-mediated homologous recombination. A light-dependent functional switch of
endogenous cellular transcription factor enabled optogenetic control of vulval cell fate specification in
C. elegans.
CRISPR interference (CRISPRi), which has been developed to study sgRNA-mediated sequence-
specific repression of transcription in prokaryotic and eukaryotic cells, was applied to C. elegans and
D. rerio [58]. Long et al. revealed that transcription initiation and elongation of a gene can be interfered
by the presence of the gRNA:DNA heteroduplex/dCas9 (a catalytically inactive form of Cas9) complex
in its promoter and exons [58].
5. Important Results Achieved Using Genome Editing Techniques
Genome editing techniques have helped to identify biological functions of genes in C. elegans [56,59–61].
TALEN-mediated genome editing has been used for the targeted inactivation of the paxt-1 gene, which
encodes a subunit of the XRN2 complex which is a eukaryotic exoribonuclease for processing and
degrading various substrates [61]. This inactivation reduced XRN2 protein levels, decreased miRNA
turnover, and caused lethality, suggesting that stabilization of XRN2 is a major function of PAXT-1.
Using gene editing, Ellis’s group has addressed the molecular mechanisms underlying the
evolution of self-fertile nematodes [29,62]. The investigators generated knock-out mutants of key genes
involved in sperm activation in C. briggsae or C. tropicalis and found that C. briggsae, C. elegans, and
C. tropicalis become self-fertile by co-opting one of the two redundant male programming pathways:
the SPE-8 tyrosine kinase pathway or the TRY-5 serine protease pathway. These pathways functioned
redundantly in ancestral males [29]. Characterizations of an identified spe-47(hc198) allele using the
CRISPR system showed that the hc198 mutation is able to bypass the SPE-8 signaling pathway to
cause premature activation of a small fraction of sperm [63]. In addition, the authors have found that
the nucleosome remodeling factor (NURF) complex has acquired a unique role in the sperm/oocyte
decision of C. briggsae [62]. This role was acquired during recent C. briggsae evolution.
Meyer and colleagues have used the CRISPR system to investigate X chromosome dosage
compensation, which balances gene expression between XX hermaphrodites and XO males [59].
Crane et al. used genome-wide chromosome conformation capture techniques to obtain three-dimensional
(3D) maps of the C. elegans genome [59]. They initially revealed that the DCC remodels X chromosomes
into a sex-specific spatial conformation distinct from autosomes. The dosage-compensated X chromosomes
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had been known to consist of self-interacting domains similar to topologically associated domains
(TADs) in mammals. To address whether DCC-dependent interactions between sequence-specific
recruitment elements on X (rex sites) create TAD boundaries, they deleted the endogenous rex-47 site
from a DCC-dependent TAD boundary using the CRISPR system. This experiment shows that the
DCC contributes to inducing and reinforcing TAD boundaries on the X chromosome by mediating
long-range interactions between its highest affinity rex sites. This critical finding led the authors to
conclude that the DCC dynamically remodels X chromosomes into a spatial conformation of TADs.
In addition to these achievements, genome editing has been a practical approach for investigating
the role of microRNAs in vulval development [60]. Ecsedi et al. have found through editing the
endogenous let-7 target site that, although let-7 has numerous targets including LET-60/RAS, it does not
function to reduce gene expression noise broadly but instead functions to direct vulval development
by regulating a single primary target, LIN-41/TRIM71 [60]. In terms of behavioral mechanism,
Uozumi et al. found through proteomic screening that the mitochondrial voltage-dependent anion
channel VDAC-1 functions as a candidate target of MAPK, and uncovered its role in olfactory behavior
using the CRISPR system [64]. Thus, the practical application of genome editing techniques has
facilitated the identification of novel roles for genes that had not been previously investigated by
genetic experiments.
6. Conclusions
In nematode species, as with other model organisms, genome editing technologies have been
used as indispensable tools for investigating biological systems. The previously available methods
to generate mutations, such as chemical mutagenesis, use laborious procedures that require at least
one month for large-scale mutagenesis screening, with unpredictable results. In contrast, recently
developed genome editing techniques allow researchers to produce specific knock-out mutants or
missense mutants in two to three weeks. Furthermore, they can conditionally create the targeted
mutations with a cell-specific promoter. This technique provides an alternative avenue to investigate
the role of a gene of interest in a cell-specific manner, avoiding the embryonic lethality caused by
some mutations.
In other model organisms, TALE and Cas9 can be altered into a transcriptional regulator when
they are fused to the transcriptional activator VP16/VP64 [65,66] or to an epigenetic factor such as
LSD1 histone demethylase [67]. Moreover, as an alternative to fluorescence in situ hybridization (FISH)
methods, fluorescently tagged Cas9 labeling of specific DNA loci has been developed as a powerful
live-cell imaging strategy [68]. These techniques should be highly compatible with C. elegans genetic
methods, in which genes are expressed in only a target cell with a cell-specific promoter. Considering
this remarkable feature, the causal roles of a gene expression change and its associated chromatin state
at the single cell level can be studied in diverse biological processes including development, learning
and memory, and disease. In summary, further promising techniques and novel biological concepts
should emerge from the combination of genome editing technology and nematode cell-specific genetics.
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